Skip to main content
SpringerLink
Log in
Book cover

Acute Endocrinology pp 1–28Cite as

Thyrotoxicosis

  • Chapter

  • 1350 Accesses

Part of the book series: Contemporary Endocrinology ((COE))

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Davies TF, Larsen PR. Thyrotoxicosis. In: Larsen PR, ed. William’s Textbook of Endocrinology, 10th edition. Philadelphia: WB Saunders Co, 2002:374–421.

    Google Scholar 

  2. Turnbridge WMG, Evered DC, Hall R. The spectrum of thyroid disease in a community. Clin Endocrinol (Oxf) 1977; 7:483–93.

    Google Scholar 

  3. Weetman AP. Graves’ Disease. NEJM 2000; 343(17):1236–1248.

    Article  CAS  PubMed  Google Scholar 

  4. Vanderpump MPJ, Tunbridge WMG. The epidemiology of autoimmune thyroid disease. In: Volpe R, ed. Autoimmune endocrinopathies. Vol 15 of Contemporary Endocrinology. Totowa, NJ: Humana Press, 1999; 141–162.

    Google Scholar 

  5. LiVolsi VA. Pathology. In: Braverman LE, Utiger RD, eds. Werner and Ingbar’s The Thyroid. 8th ed. Philadelphia: Lippincott Williams and Wilkins, 2000:488–511.

    Google Scholar 

  6. Nayak B, Hodak SB. Hyperthyroidism. Endocrinol Metab Clin N Am 2007; 36(3):617–656.

    Article  CAS  Google Scholar 

  7. Bartalena L, Bogazzi F, Tanda ML, Manetti L, Dell’Unto E, Martino E. Cigarette smoking and the thyroid. Eur J Endocrinol 1995; 133:507–512.

    Article  CAS  PubMed  Google Scholar 

  8. Wiersinga WM, Bartalena L. Epidemiology and Prevention of Graves’ Ophthalmopathy. Thyroid 2002; 12(10):855–860.

    Article  PubMed  Google Scholar 

  9. Burch HB, Wartofsky L. Graves’ ophthalmopathy: Current concepts regarding pathogenesis and management. Endocr Rev 1993; 14:747–793.

    CAS  PubMed  Google Scholar 

  10. Matovinovic J. Endemic goiter and cretinism at the dawn of the third millennium. Annu Rev Nutr 1983; 3:341–412.

    Article  CAS  PubMed  Google Scholar 

  11. Daniels GH. Thyroid nodules and nodular thyroids: a clinical overview. Compr Ther 1996; 22:239–250.

    CAS  PubMed  Google Scholar 

  12. Day TA, Chu A, Hoang KG. Multinodular Goiter. Otolaryngol Clin N Am 2003; 36:35–54.

    Article  Google Scholar 

  13. Okamoto T, Iihara M, Obara T. Management of Hyperthyroidism Due to Graves’ and Nodular Diseases. World J Surg 2000; 24:957–961.

    Article  CAS  PubMed  Google Scholar 

  14. Pacella CM, Bizzarri G, Spiezia S et al. Thyroid tissue: US-guided percutaneous laser thermal ablation. Radiology 2004; 232:272–280.

    Article  PubMed  Google Scholar 

  15. Mauz PS, Maassen MM, Braun B et al. How safe is percutaneous ethanol injection for treatment of thyroid nodule? Report of a case of severe toxic necrosis of the larynx and adjacent skin. Acta Otolaryngol 2004; 124:1226–1230.

    Article  CAS  PubMed  Google Scholar 

  16. Greene JN. Subacute thyroiditis, Am J Med 1971; 51:97–108.

    Article  CAS  PubMed  Google Scholar 

  17. Pearce EN, Marino E, Bogazzi F, et al. The prevalence of elevated serum C-reactive protein levels in inflammatory and noninflammatory thyroid disease. Thyroid 2003; 13(7):643–648.

    Article  PubMed  Google Scholar 

  18. Farwell AP, Braverman LE. Inflammatory thyroid disorders. Otolaryngol Clin North Am 1999; 4:541–556.

    Google Scholar 

  19. Kitchener MI, Chapman IM. Subacute thyroiditis: a review of 105 cases. Clin Nucl Med 1989; 14:439–442.

    Article  CAS  PubMed  Google Scholar 

  20. Woolf PD. Transient painless thyroiditis with hyperthyroidism: a variant of lymphocytic thyroiditis? Endocr Rev 1980; 1:411–420.

    Article  CAS  PubMed  Google Scholar 

  21. Pearce EN, Farwell AP, Braverman LE. Thyroiditis. NEJM 2003; 348:2646–2655.

    Article  PubMed  Google Scholar 

  22. Premawardhana LD, Parkes AB, Ammari F, et al. Postpartum thyroiditis and long-term thyroid status: prognostic influence of thyroid peroxidase antibodies and ultrasound echogenicity. J Clin Endocrinol Metab 2000; 85:71–75.

    Article  CAS  PubMed  Google Scholar 

  23. Roti E, Emerson CH. Postpartum Thyroiditis. J Clin Endocrinol Metab 1992; 74:3–5.

    Article  CAS  PubMed  Google Scholar 

  24. Surks, MI. Iodine and Thyroid Function. In: UpToDate, Rose, BD (Ed), UpToDate, Waltham, MA, 2007.

    Google Scholar 

  25. Chaudhry, GM, Haffajee, CI. Antiarrhythmic agents and proarrhythmia. Crit Care Med 2000; 28:N158–N164.

    Article  CAS  PubMed  Google Scholar 

  26. Hohnloser, SH. Proarrhythmia with Class III Antiarrhythmic Drugs: Types, Risks, and Management. Am J Cardiol 1997; 80(8A):82G–89G.

    Article  CAS  PubMed  Google Scholar 

  27. Martino, E, Bartalena L, Bogazzi F, et al. The Effects of Amiodarone on the Thyroid. Endocr Rev 2001; 22:240–254.

    Article  CAS  PubMed  Google Scholar 

  28. Daniels, G. Amiodarone-Induced Thryotoxicosis. JCEM 2001; 86:3–8.

    CAS  PubMed  Google Scholar 

  29. Zipes, DP, Prystowsky EN, Heger JS. Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects. J Am Coll Cardiol 1984; 3:1059–1071.

    Article  CAS  PubMed  Google Scholar 

  30. Basaria, S, Cooper, DS. Amiodarone and the thyroid. Am J Med 2005; 118:705–714.

    Article  Google Scholar 

  31. Bogazzi, F, Bartalena L, Brogioni S, et al. Color flow Doppler sonography rapidly differentiates type 1 and type II amiodarone-induced thyrotoxicosis. Thyroid 1997; 7:541–545.

    Article  CAS  PubMed  Google Scholar 

  32. Osman, F, Franklyn JA, Sheppard MC, Gammage MD. Successful Treatment of Amiodarone-Induced Thyrotoxicosis. Circulation 2002; 105:1275–1277.

    CAS  PubMed  Google Scholar 

  33. Sato K, Yamazaki K, Kanaji Y, et al. Amiodarone-induced thyrotoxicosis associated with thryotropin receptor antibody. Thyroid 1998; 8:1123–1126.

    Article  CAS  PubMed  Google Scholar 

  34. Reichert L, de Rooy H. Treatment of amiodarone induced hyperthyroidism with potassium perchlorate and methimazole during amiodarone treatment. BMJ 1989; 298:1547–1548.

    Article  CAS  PubMed  Google Scholar 

  35. Bartalena L, Brogioni S, Grasso L, et al. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. J Clin Endocrinol Metab 1996; 81(8):2940–2933.

    Article  Google Scholar 

  36. Soldin OP, Braverman LE, Lamm SH. Perchlorate clinical pharmacology and human health: a review. Ther Drug Monit 2001; 23:316–331.

    Article  CAS  PubMed  Google Scholar 

  37. Martino E, Aghini-Lombardi F, Mariotti S. Treatment of amiodarone-associated thryotoxicosis by simultaneous administration of potassium perchlorate and methimazole. J Endocrinol Invest 1986; 9:201–207.

    CAS  PubMed  Google Scholar 

  38. Ergodan MF, Gulec S, Tutar E, et al. A stepwise approach to the treatment of amiodarone-induced thyrotoxicosis. Thyroid 2003; 13:205–209.

    Article  Google Scholar 

  39. Gough J, Gough IR. Total thyroidectomy for amiodarone-associated thyrotoxicosis in patients with severe cardiac disease. World J Surg 2006; 30:1957–1961.

    Article  PubMed  Google Scholar 

  40. Houghton SG, Farley DR, Brennan MD, et al. Surgical management of amiodarone-associated thyrotoxicosis: Mayo Clinic Experience. World J Surg 2004; 28:1083–1087.

    Article  PubMed  Google Scholar 

  41. Hershman JM. Human Chorionic Gonadotropin and the Thyroid: Hyperemesis Gravidarum and Trophoblastic Tumors. Thyroid 1999; 9(7):653–657.

    Article  CAS  PubMed  Google Scholar 

  42. Goodarzi MO, Van Herle AJ. Thyrotoxicosis in a Male Patient Associated with Excess Human Chorionic Gonadotropin Production by Germ Cell Tumor. Thyroid 2000; 10(7):611–619.

    Article  CAS  PubMed  Google Scholar 

  43. Fisher PM, Hancock BW. Gestational trophoblastic disease and their treatment. Cancer Treatment Rev 1997; 23:1–16.

    Article  CAS  Google Scholar 

  44. Beck-Peccoz P, Brucker-Davis F, Persani L, et al. Thyrotropin-Secreting Pituitary Tumors. Endocr Rev 1996; 17(6):610–638.

    CAS  PubMed  Google Scholar 

  45. Brucker-Davis F, Oldfield EH, Skarulis MC, et al. Thyrotropin-Secreting Pituitary Tumors: Diagnostic Criteria, Thyroid Hormone Sensitivity, and Treatment Outcome in 25 Patients Followed at the National Institutes of Health. J Clin Endocrinol Metab 1999; 84(2):476–486.

    Article  CAS  PubMed  Google Scholar 

  46. Beck-Peccoz P, Persani L. Medical Management of Thyrotropin-Secreting Pituitary Adenomas. Pituitary 2002; 5:83–88.

    Article  CAS  PubMed  Google Scholar 

  47. Beck-Peccoz P, Piscitelli G, Amr S, et al. Endocrine, biochemical, and morphological studies of a pituitary adenoma secreting growth hormone, thyrotropin (TSH), and alpha-subunit: evidence for secretion of TSH with increased bioactivity. JCEM 1986; 62(4):704–11.

    CAS  PubMed  Google Scholar 

  48. Socin HV, Chanson P, Delemer B, et al. The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. Eur J Endocrinol 2003; 148:433–442.

    Article  CAS  PubMed  Google Scholar 

  49. Refetoff S, Weiss RA, Usala SJ. The syndromes of resistance to thyroid hormone. Endocr Rev 1993; 14:348–399.

    CAS  PubMed  Google Scholar 

  50. Brucker-Davis F, Skarulis MC, Grace MB, et al. Genetic and Clinical Features of 42 kindreds with resistance to thyroid hormone. The National Institutes of Health Prospective Study. Annals of Int Med 1995; 123:572–583.

    CAS  Google Scholar 

  51. Olattegu T, Vanderpump M. Thyroid Hormone resistance. Ann Clin Biochem 2006; 43:431–440.

    Article  Google Scholar 

  52. Bogazzi F, Bartelena L, Scarcello G, et al. The age of patients with thyrotoxicosis factitia in Italy from 1973 to 1996. J Endocrinol Invest 1999; 22(2):128–133.

    CAS  PubMed  Google Scholar 

  53. Daniels GH. Hyperthyroidism: multiple possibilities in the female patient. 1999; 44(1):6–11.

    CAS  Google Scholar 

  54. Bauer BA, Elkin PL, Erickson D, et al. Symptomatic Hyperthyroidism in a Patient Taking the Dietary Supplement Tiratricol: Case Report. Mayo Clin Proc 2002; 77(6):587–590.

    Article  Google Scholar 

  55. Ayan A, Yanik F, Tuncer R, et al. Struma ovarii. Int J Gynecol Obstet 1993; 118(2):112–113.

    Google Scholar 

  56. Grandet PJ, Remi MH. Struma ovarii with hyperthyroidism. Clin Nucl Med 2000; 25(10):763–765.

    Article  CAS  PubMed  Google Scholar 

  57. Joja I, Asakawa T, Mitsumori A, et al. I-123 uptake in nonfunctional struma ovarii. Clin Nuc Med 1998; 23:10–12.

    Article  CAS  Google Scholar 

  58. Nahn PA, Robinson E, Strassman M. Conservative therapy for malignant struma ovarii: a case report. J Reprod Med 2002; 47:943–945.

    PubMed  Google Scholar 

  59. Tardy M, Tavernier E, Sautot G, et al. A case of hyperthyroidism due to functioning metastasis of differentiated thyroid carcinoma: Discussion and literature review. Ann Endocrinol 2007; 68(1):39–44.

    Article  CAS  Google Scholar 

  60. Paul SJ, Sisson JC. Thyrotoxicosis caused by thyroid cancer. Endocrinol Metab Clin North Am 1990; 19(3):593–612.

    CAS  PubMed  Google Scholar 

  61. Salvatori M, Saletnich I, Rufini V, et al. Severe Thyrotoxicosis Due to Functioning Pulmonay Metastases of Well-Differentiated Thyroid Cancer. J Nucl Med 1998; 39(7):1202–1207.

    CAS  PubMed  Google Scholar 

  62. Toft AD. Subclinical Hyperthyroidism. NEJM 2001; 345(7):512–516.

    Article  CAS  PubMed  Google Scholar 

  63. Hallowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988–1994): National Institutes of Health and Nutrition Examination Survey (NHANES III). JCEM 2002; 87(2):489–499.

    Google Scholar 

  64. Cooper DS. Approach to the patient with subclinical hyperthyroidism. JCEM 2007; 92(1):3–9.

    CAS  PubMed  Google Scholar 

  65. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004; 291(2):228–238.

    Article  CAS  PubMed  Google Scholar 

  66. Burch HB, Wartofsky L. Life-Threatening Thyrotoxicosis: Thyroid Storm. Endocrinol Metab Clin North Am 1993; 22(2):263–277.

    CAS  PubMed  Google Scholar 

  67. Boehm TM, McLain J, Burman KD, et al. Iodine treatment of iodine-induced thyrotoxicosis. J Endocrinol Invest 1980; 4:418–424.

    Google Scholar 

  68. Boehm TM, Burman KD, Barnes S, et al. Lithium and iodine combination therapy for thyrotoxicosis. Acta Endocrinologica 1980; 94:174–183.

    CAS  PubMed  Google Scholar 

  69. Cooper, DS. Antithyroid Drugs. NEJM 2005; 352:905–917.

    Article  CAS  PubMed  Google Scholar 

  70. Abraham P, Avenell A, Watson WA, et al. Antithyroid drug regimen for treating Graves’ hyperthyroidism. Cochrane Database Syst Rev 2004; 2:CD003420.

    PubMed  Google Scholar 

  71. Vitti P, Rago T, Chiovato L, et al. Clinical features of patients with Graves’ disease undergoing remission after antithyroid drug treatment. Thyroid 1997; 7:369–375.

    Article  CAS  PubMed  Google Scholar 

  72. Cooper DS. The side effects of antithyroid drugs. Endocrinologist 1999; 9:457–476.

    Article  Google Scholar 

  73. Wing SS, Fantus GI. Adverse Immunologic Effects of Antithyroid Drugs. CMAJ 1987; 136:121–127.

    CAS  PubMed  Google Scholar 

  74. Wiik A. Clinical and laboratory characteristics of drug-induced vaculitic syndromes. Arthritis Res Therapy 2005; 7:191–192.

    Article  CAS  Google Scholar 

  75. Tajiri J, Noguchi S. Antithyroid drug-induced agranulocytosis: special reference to normal white blood cell count agranulocytosis. Thyroid 2004; 14:459–462.

    Article  CAS  PubMed  Google Scholar 

  76. Tajiri J, Noguchi S, Murakami T, et al. Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring. Arch Int Med 1990; 150(3):621–624.

    Article  CAS  Google Scholar 

  77. Metso S, Auvinen A, Salmi J, et al. Increased long-term cardiovascular morbidity among patients treated with radioactive iodine for hyperthyroidism. Clin Endocrinol 2007; Epub:1–8.

    Google Scholar 

  78. Franklyn JA, Maisonneuve P, Sheppard MC, et al. Mortality after the Treatment of Hyperthyroidism with Radioactive Iodine. NEJM 1998; 338:712–718.

    Article  CAS  PubMed  Google Scholar 

  79. Iagaru A, McDougall IR. Treatment of Thyrotoxicosis. J Nucl Med 2007; 48:379–389.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Endocrine Section, Washington Hospital Center, Georgetown University School of Medicine, Washington DC, USA

    Powlimi J. Nadkarni & Burman D. Kenneth MD

Authors
  1. Powlimi J. Nadkarni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Burman D. Kenneth MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Nadkarni, P.J., Kenneth, B.D. (2008). Thyrotoxicosis. In: Acute Endocrinology. Contemporary Endocrinology. Humana Press. https://doi.org/10.1007/978-1-60327-177-6_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-177-6_1

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-176-9

  • Online ISBN: 978-1-60327-177-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation